Clark W. LeMasters Jr.

BWX Technologies to Host Investor Day on February 28, 2024

Retrieved on: 
Friday, December 15, 2023
Other Defense, Contracts, Alternative Energy, Aerospace, Energy, Green Technology, Manufacturing, Government Technology, Technology, Nuclear, Defense, Environment, Other Technology, Other Manufacturing, Engineering, BWXT, BWX Technologies, NYSE, Senior, Clark W. LeMasters Jr., Cryptocurrency

BWX Technologies, Inc. (NYSE: BWXT) today announced that it will host an Investor Day with financial analysts and institutional investors on Wednesday, February 28, 2024.

Key Points: 
  • BWX Technologies, Inc. (NYSE: BWXT) today announced that it will host an Investor Day with financial analysts and institutional investors on Wednesday, February 28, 2024.
  • The event will be held live at the New York Stock Exchange and feature presentations by BWXT’s President and Chief Executive Officer Rex D. Geveden, Senior Vice President and Chief Financial Officer Robb A. LeMasters and other leaders from across the company, followed by a live question and answer session.
  • A link to the live webcast of the Investor Day, replay, and presentation slides will be available on BWXT’s Investor Relations website at investors.bwxt.com .

MBrace Therapeutics Raises $85 Million Series B Financing to Advance Oncology Pipeline of Innovative Antibody Drug Conjugate Candidates

Retrieved on: 
Tuesday, November 14, 2023
Research, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Other Science, Science, Oncology, MBrace, TPG, Breast, Spacecraft, Therapy, State university system, Annexin A5, ADC, Clinical trial, Patient, Doctor of Philosophy, Ng, Rutgers University, Cancer, Alta Partners, MBA, Clark W. LeMasters Jr., NSCLC, Pharmaceutical industry, Venrock

Funds will be used to support clinical development programs, including a first-in-human clinical trial of lead investigational ADC, MBRC-101.

Key Points: 
  • Funds will be used to support clinical development programs, including a first-in-human clinical trial of lead investigational ADC, MBRC-101.
  • The round also included new investors Avidity Partners and Cowen Healthcare Investments, as well as existing Series A investors, Venrock and Alta Partners.
  • MBrace has generated extensive preclinical data on novel drug candidates in-licensed from Rutgers, The State University of New Jersey.
  • XinThera is a subsidiary of Gilead Pharmaceuticals that is focused on small molecule discovery and development of oncology and immunology therapeutics.

Hospital PMI® at 52.1%; October 2023 Hospital ISM® Report On Business®

Retrieved on: 
Tuesday, November 7, 2023
Spend, IV, Monster Employment Index, Days payable outstanding, MBA, Clark W. LeMasters Jr., Growth, Business, Hospital, Case mix index, Tourism

The Business Activity Index expanded for the second consecutive month.

Key Points: 
  • The Business Activity Index expanded for the second consecutive month.
  • The New Orders Index remained in expansion for the second straight month, and the Employment Index returned to contraction territory.
  • LeMaster continues, "While slightly lower than the previous month, volume metrics remained in the growth range; Hospital Business Survey Committee respondents commented that operations were stable.
  • There is concern that a potential shortage of IV fluids and related products could cause serious issues going into flu season."

Hospital PMI® at 52.5%; January 2023 Hospital ISM® Report On Business®

Retrieved on: 
Tuesday, February 7, 2023
Spend, MBA, Monster Employment Index, RSV, Hospital, Respiratory syncytial virus, Case mix index, Days payable outstanding, Clark W. LeMasters Jr., Growth, Plastic, Non-Manufacturing Business Activity Index, PPE, COVID-19, Nursing

TEMPE, Ariz., Feb. 7, 2023 /PRNewswire/ -- Economic activity in the hospital subsector grew in January for the 32nd consecutive month, say the nation's hospital supply executives in the latest Hospital ISM® Report On Business®.

Key Points: 
  • TEMPE, Ariz., Feb. 7, 2023 /PRNewswire/ -- Economic activity in the hospital subsector grew in January for the 32nd consecutive month, say the nation's hospital supply executives in the latest Hospital ISM® Report On Business®.
  • The Case Mix Index registered 56.5 percent, an increase of 4.5 percentage points compared to the December figure of 52 percent.
  • The Days Payable Outstanding Index registered 53 percent, up 1.5 percentage points from the 51.5 percent reported in December.
  • They indicated confidence that respiratory illnesses are declining and a 'steady state' of COVID-19 cases is being achieved."

Hospital PMI® at 57%; December 2022 Hospital ISM® Report On Business®

Retrieved on: 
Monday, January 9, 2023
Spend, Days payable outstanding, Blood, RSV, COVID-19, Workforce, MBA, Clark W. LeMasters Jr., Growth, Patient, Absenteeism, Monster Employment Index, Non-Manufacturing Business Activity Index, Hospital, Case mix index, Medicine

TEMPE, Ariz., Jan. 9, 2023 /PRNewswire/ -- Economic activity in the hospital subsector grew in December for the 31st consecutive month, say the nation's hospital supply executives in the latest Hospital ISM® Report On Business®.

Key Points: 
  • TEMPE, Ariz., Jan. 9, 2023 /PRNewswire/ -- Economic activity in the hospital subsector grew in December for the 31st consecutive month, say the nation's hospital supply executives in the latest Hospital ISM® Report On Business®.
  • The Case Mix Index registered 52 percent, a decrease of 5.5 percentage points compared to the November figure of 57.5 percent.
  • The Days Payable Outstanding Index registered 51.5 percent, up 1.5 percentage points from the 50 percent reported in November.
  • The Technology Spend Index registered 55.5 percent, an 8.5-percentage point decrease from the November reading of 64 percent."

BWXT Names Robb A. LeMasters as Next Chief Financial Officer

Retrieved on: 
Friday, November 5, 2021
Other Defense, Contracts, Other Energy, Nuclear, Alternative Energy, Energy, Defense, Environment, Other Manufacturing, Engineering, Aerospace, Manufacturing, People, BWX Technologies, University, Master of Business Administration, Blue Harbour Group, Culture, Defense News, Highbridge Capital Management, Fortune 1000, United States Department of Energy, Growth, Morgan Stanley, Nuclear medicine, Relative, BWXT, Wendell Pritchett, NASA, Twitter, Forstmann Little & Company, Wharton School of the University of Pennsylvania, Business administration, NYSE, Clark W. LeMasters Jr., Harvard Business School, CFO, Triple accreditation, Management, Renewable energy

BWX Technologies, Inc. (NYSE: BWXT) announced today that as part of BWXTs executive succession planning process, Robb A. LeMasters has been named senior vice president and chief financial officer effective November 15, 2021.

Key Points: 
  • BWX Technologies, Inc. (NYSE: BWXT) announced today that as part of BWXTs executive succession planning process, Robb A. LeMasters has been named senior vice president and chief financial officer effective November 15, 2021.
  • LeMasters will succeed David S. Black, who will retire after 30 years of service to BWXT.
  • He assumed positions of greater responsibility with the company, culminating with his appointment as senior vice president and chief financial officer in 2015.
  • Black will remain with the company through April 1, 2022, working as a special advisor to Rex Geveden, president and chief executive officer.